Pharmacokinetics of novel Fc-engineered monoclonal and multispecific antibodies in cynomolgus monkeys and humanized FcRn transgenic mouse models

Monoclonal antibodies (mAbs) are among the fastest growing and most effective therapies for myriad diseases. Multispecific antibodies are an emerging class of novel therapeutics that can target more than one tumor- or immune-associated modulators per molecule. The combination of different binding af...

Descripción completa

Detalles Bibliográficos
Autores principales: Valente, Delphine, Mauriac, Christine, Schmidt, Thorsten, Focken, Ingo, Beninga, Jochen, Mackness, Brian, Qiu, Huawei, Vicat, Pascale, Kandira, Abdullah, Radošević, Katarina, Rao, Srini, Darbyshire, John, Kabiri, Mostafa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7587234/
https://www.ncbi.nlm.nih.gov/pubmed/33079615
http://dx.doi.org/10.1080/19420862.2020.1829337

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7587234/
https://www.ncbi.nlm.nih.gov/pubmed/33079615
http://dx.doi.org/10.1080/19420862.2020.1829337

Ejemplares similares